Company / Income Tax
Syndax Pharmaceuticals Inc Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$433.0K
FY2025
5-year range
$0 / $433.0K
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#91 of 204
Health Care
What the data says
At $433,000, Syndax Pharmaceuticals Inc's income tax ranks #114 of 204 in the Health Care sector. Increased from $0 to $433,000 over the past 5 years.
Based on SEC 10-K filings.
$433,000 in FY2025.
Increased from $0 to $433,000 over the past 5 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#114 of 204 in Health CareTop 55% of 204This company $433.0K Sector average $118.7M
▼
-99.6% below sector average
Key checks
Key Insights
- Ranks #91 out of 204 companies in the Health Care sector.
- Lowest income tax in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $433.0K | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026